11/20/2014 - 10:18am

The Consumer Healthcare Products Association board of directors on Wednesday announced changes to CHPA’s voluntary guidelines addressing dosing of liquid pediatric over-the-counter medicines.

11/19/2014 - 9:59am

The Food and Drug Administration opened a public docket and requested comments on proposed criteria for “first generic” abbreviated new drug application submissions.

 

11/17/2014 - 6:45pm

Thirty years ago, Democratic and Republican members of Congress hammered out a rare and prescient bipartisan compromise bill that transformed the pharmaceutical landscape forever and unleashed the modern generic drug industry. That law, known as the Hatch-Waxman Act, has proven to be one of the most far-reaching and impactful pieces of legislation ever to shape the American healthcare system.

11/17/2014 - 10:16am

Solgar on Friday voluntarily recalled its ABC Dophilus Powder.

11/14/2014 - 10:23am

Almost 23% of high school students currently use a tobacco product, according to new data published by the Centers for Disease Control and Prevention.

 

11/14/2014 - 10:15am

The Council for Responsible Nutrition has launched a tool that compiles Food and Drug Administration warning letters sent to dietary supplement companies into a searchable database.

11/14/2014 - 10:07am

Each year Americans make nearly a million doctor visits for eye infections, resulting in $175 million in direct healthcare costs, the Centers for Disease Control and Prevention estimated.

11/13/2014 - 2:17pm

 Janssen Pharmaceuticals announced that the Food and Drug Administration approved the company's supplemental new drug application for the once-monthly Invega Sustenna (paliperidone palmitate), an antipsychotic used to treat schizoaffective disorder as either monotherapy or adjunctive therapy. 

11/11/2014 - 10:01am

Dr. Reddy's Labs received approval from the Food and Drug Administration for a generic version of Roche Holding's antiviral medication Valcyte, according to a Reuters report